Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(4-methoxycyclohexyl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1h)-one
2. Cc0482223
1. 1228013-30-6
2. Onatasertib
3. Cc223
4. Onatasertib [usan]
5. Atg-008
6. I8ra3543sy
7. Chembl3586404
8. Cc 223
9. Onatasertib (usan)
10. 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((1r,4r)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
11. 3-[6-(2-hydroxypropan-2-yl)pyridin-3-yl]-5-(4-methoxycyclohexyl)-7,8-dihydropyrazino[2,3-b]pyrazin-6-one
12. 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(trans-4-methoxycyclohexyl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1h)-one
13. 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(trans-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
14. Pyrazino(2,3-b)pyrazin-2(1h)-one, 3,4-dihydro-7-(6-(1-hydroxy-1-methylethyl)-3-pyridinyl)-1-(trans-4-methoxycyclohexyl)-
15. Pyrazino[2,3-b]pyrazin-2(1h)-one, 3,4-dihydro-7-[6-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-(trans-4-methoxycyclohexyl)-
16. Compound 37 [pmid: 26083478]
17. Onatasertib [inn]
18. Unii-i8ra3543sy
19. Onatasertib [who-dd]
20. Schembl138069
21. Schembl153700
22. Schembl800493
23. Gtpl8914
24. Schembl16272828
25. Ex-a781
26. Bcp09953
27. Bdbm50092783
28. Mfcd28976054
29. Nsc792971
30. Nsc800982
31. S7886
32. Who 11237
33. Akos030526335
34. Zinc113219373
35. Zinc114617828
36. Ccg-268624
37. Cs-4560
38. Db12570
39. Nsc-792971
40. Nsc-800982
41. Sb19154
42. Ac-31533
43. As-35243
44. Hy-16956
45. Ft-0700128
46. A13078
47. D11663
48. J-690077
49. Q27075761
50. 1-((1beta,4alpha)-4-methoxycyclohexane-1-yl)-7-(2-(1-methyl-1-hydroxyethyl)-5-pyridyl)-1,2,3,4-tetrahydropyrazino[2,3-b]pyrazine-2-one
51. 3,4-dihydro-7-(6-(1-hydroxy-1-methylethyl)-3-pyridinyl)-1-(trans-4-methoxycyclohexyl)pyrazino(2,3-b)pyrazin-2(1h)-one
52. 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
| Molecular Weight | 397.5 g/mol |
|---|---|
| Molecular Formula | C21H27N5O3 |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 397.21138974 g/mol |
| Monoisotopic Mass | 397.21138974 g/mol |
| Topological Polar Surface Area | 101 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 581 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
63
PharmaCompass offers a list of Onatasertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Onatasertib manufacturer or Onatasertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Onatasertib manufacturer or Onatasertib supplier.
PharmaCompass also assists you with knowing the Onatasertib API Price utilized in the formulation of products. Onatasertib API Price is not always fixed or binding as the Onatasertib Price is obtained through a variety of data sources. The Onatasertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Onatasertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Onatasertib, including repackagers and relabelers. The FDA regulates Onatasertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Onatasertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Onatasertib supplier is an individual or a company that provides Onatasertib active pharmaceutical ingredient (API) or Onatasertib finished formulations upon request. The Onatasertib suppliers may include Onatasertib API manufacturers, exporters, distributors and traders.
Onatasertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Onatasertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Onatasertib GMP manufacturer or Onatasertib GMP API supplier for your needs.
A Onatasertib CoA (Certificate of Analysis) is a formal document that attests to Onatasertib's compliance with Onatasertib specifications and serves as a tool for batch-level quality control.
Onatasertib CoA mostly includes findings from lab analyses of a specific batch. For each Onatasertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Onatasertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Onatasertib EP), Onatasertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Onatasertib USP).
